Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States ...(he Medicare Part DPrescription Drug Prog...),Health
Navigation Links
Southeast Michigan ePrescribing Initiative (SEMI) Drives Michigan into Top Five ePrescribing States Nationally
Date:3/7/2008
he Medicare Part D Prescription Drug Program. Medco, the world's most advanced pharmacy(TM), is positioned to serve the unique needs of patients with chronic and complex conditions through its Medco Therapeutic Resource Centers(R); its diabetes pharmacy care practice, Liberty Medical; and its specialty pharmacy operation, Accredo Health Group, Inc. Medco is the highest-ranked independent pharmacy benefit manager on the 2007 Fortune 500 list. On the Net: http://www.medco.com.
About CVS Caremark
CVS Caremark (NYSE: CVS) is the largest provider of prescriptions and related healthcare services in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of healthcare services in the U.S. The Company is uniquely positioned to effectively manage costs and improve healthcare outcomes through its 6,200 CVS/pharmacy stores; its pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investor Relations portion of the Company's website, at http://investor.cvs.com, as well as through the pressroom portion of the Company's website, at http://www.cvs.com/pressroom.
'/>"/>
| SOURCE Southeast Michigan ePrescribing Initiative Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Eastern Alliance Insurance Group Appoints Cox Regional Marketing Director for Southeast
2. RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US
3. Generic Prescription Drugs Show Increasingly Greater Use in Southeastern Pennsylvania
4. Oakwood is First Healthcare System in Southeast Michigan to Post Pricing Information on Web Site
5. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
6. A Safe Bet for Medicare Beneficiaries in the Southeast
7. American Red Cross Responds to Tornadoes in the Southeast
8. Meetings Set in Southeast PA to Help State Retirees Choose Best Plan to Continue Health Care Benefits
9. Blue Cross Blue Shield of Michigan Corrects News Story about Drug Coverage Announcement
10. Education Key Focus of Michigan Policy Summit
11. Michigan Hospitals Receive Governors Award
Post Your Comments:
(Date:12/4/2009)... YORK, Dec. 4 Thousands of KPMG LLP employees came ... in a community service event which combines the audit, tax ... ,, "This national service day reflects our firm,s long history ... the spirit of caring to brighten the holidays for some ...
(Date:12/4/2009)... Allied World Assurance,Company Holdings, Ltd (NYSE: ... Executive Officer, and Jack Sennott, Executive Vice,President and Chief ... Sachs U.S. Financial Services Conference being held at the ... December 8, 2009. ,, About ...
(Date:12/4/2009)... Dec. 4 Healthcare Trust of America, Inc. ("HTA"), ... execution of a purchase and sale agreement to acquire ... Angelo, Texas, Corsicana, Texas, and Fort Wayne, Indiana for ... subject to the satisfaction of a number of conditions. ...
(Date:12/4/2009)... Mich., Dec. 4 The Editorial Advisory and Securities Review ... Inc. (NYSE: AGN ) as its February ... (NYSE: BCR ) as its February 2010 "Undervalued ... chose Allergan because of growth opportunities involving its flagship drug ...
(Date:12/4/2009)... whether health care reform would control health care ... that lead through example -- delivering the best ... highest levels of efficiency. Thirty-four urban, eight children,s ... Leapfrog Top Hospitals, based on results from The ...
Breaking Medicine News(10 mins):Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3[0] KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children[0] Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference[0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana[0] BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use[0] The Leapfrog Group Releases Its 2009 Top Hospitals List
... Forest Laboratories, Inc.,(NYSE: FRX ), an international ... Fiscal 2008 Third Quarter financial results,before the U.S. ... Later that,day, at 10:00 AM EST, Forest will ... and Chief Operating Officer and Frank Perier, Senior,Vice ...
... Torchmark Corporation,(NYSE: TMK ) announced today ... subsidiaries, United American Life Insurance Company, and Globe,Life ... Torchmark,plans to redomesticate other of its subsidiaries to ... in a number of states, as well as ...
... Watson,Pharmaceuticals, Inc. (NYSE: WPI ), a ... received final approval from the,United States (U.S.) Food ... Application (ANDA) for Ipratropium Bromide and Albuterol Sulfate,Inhalation ... Watson,s Ipratropium Bromide and Albuterol Sulfate product is ...
... Roxane Laboratories, Inc.,announced today the approval ... Granisetron Hydrochloride Tablets, 1mg by the U.S. ... in Unit Dose Blisters and is,available for ... (Logo: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO ), ...
... Bedford Laboratories(TM), a,division of Ben Venue ... citrate) Injection and CAFCIT(R) (caffeine citrate),Oral Solution ... is now the,reference listed drug holder. CAFCIT(R) ... treatment of apnea in premature infants between ...
... which children are at risk for malignancy, experts say ... scientists have discovered that children who have cancer also ... curvature of the spine. , This suggests that the ... anomaly, raising hopes that genetic information may help identify ...
Other Medicine News:Health News:Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter Earnings 2Health News:Watson Receives FDA Approval for Generic DuoNeb(R) 2Health News:Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mg 2Health News:Bedford Laboratories(TM) Announces the Acquisition of CAFCIT(R) (Caffeine Citrate) Injection CAFCIT(R) (Caffeine Citrate) Oral Solution 2Health News:Body Abnormalities, Childhood Cancer May Share Genes 2Health News:Body Abnormalities, Childhood Cancer May Share Genes 3Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Third Quarter EarningsTorchmark Corporation Announces Change in Domicile State of Insurance Subsidiaries to NebraskaWatson Receives FDA Approval for Generic DuoNeb(R)Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mgBedford Laboratories(TM) Announces the Acquisition of CAFCIT(R) (Caffeine Citrate) Injection CAFCIT(R) (Caffeine Citrate) Oral SolutionBody Abnormalities, Childhood Cancer May Share Genes
(Date:12/4/2009)... Dec. 4 Northwest Biotherapeutics, Inc. ("NWBT" or the ... US Patent and Trademark Office has allowed its patent ... stages of the manufacture of the Company,s DCVax® therapeutic ... to the very high concentration of dendritic cells (which ...
(Date:12/3/2009)... Pa., Dec. 3 Ambry Genetics and SoftGenetics ... provide extended bioinformatics genomics services using SoftGenetics, NextGENe ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20090428/LA06744LOGO ) ... team at Ambry has been providing genomics solutions ...
(Date:12/3/2009)... imaging leader MEDRAD, Inc. demonstrated PACS* injection-record integration ... North America in Chicago. The Connect.PACS(TM) ... of its kind, is the latest release in ... . ,, (Photo: http://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
Breaking Medicine Technology:Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3deCODE Receives Delisting Notice From Nasdaq Plans to Appeal 14968 1deCODE Receives Delisting Notice From Nasdaq Plans to Appeal 14968 2deCODE Receives Delisting Notice From Nasdaq Plans to Appeal 14968 3Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 6516 1Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 6516 2Dangerous Toys Still on Store Shelves Report Finds 62059 1Dangerous Toys Still on Store Shelves Report Finds 62059 2Dangerous Toys Still on Store Shelves Report Finds 62059 3[0] Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing[0] Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects[0] MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009
... Minimal Weight Change Reported Unlike What Is Commonly ... – Novo Nordisk today announced,results of a new ... insulin Levemir® (insulin detemir [rDNA origin],injection). Patients ... own dosage of Levemir® and achieve improvements in ...
... 2007 - New data from an,investigational study ... Annual Scientific Sessions showed that initial,combination therapy ... in markers of beta cell,function in patients ... function determines the ability of the body ...
Other Medicine Technology:New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 2New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 3New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 4New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment Levemir 5An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 2An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 3An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 4An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 5An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 6An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 7An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 8An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 9An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 10An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 11An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 12An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 13An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 14An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 15An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 16An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 17An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 18An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 19An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 20An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 21An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 22An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 23An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 24An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 25An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 26An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 27An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 28An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 29An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 30An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 31An Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes 32New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes,Using Self-Adjusted Dosing Starting With Once-Daily Insulin,Treatment LevemirAn Investigational Study Released at ADA Showed that Initial,Combination Therapy with Januvia (sitagliptin) and Metformin Led to,Improvement in Markers of Beta Cell Function in Patients with Type,2 Diabetes
Steel Knife with box for the Series 8000 Sliding Microtome. C-Profile, 240 x 33 x13m, 22 Degree angle, tapped to accept holder for Shandon knife sharpener....
... M3500 Radial Microtome has a look that is ... range of functions and capabilities that will please ... years of experience and knowledge but still breaking ... M3500 Microtome will be the answer to many ...
Clock oil, 6 grams net...
Coarse abrasive for knife sharpening, 6 grams net...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |